SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

Renewed tariff threats against European allies, stemming from the Greenland situation, are currently dominating market discourse for SPY and impacting futures. While some investors anticipate a significant market pullback, many view any dip as a familiar "buy the dip" opportunity, expecting a rapid recovery as markets have previously navigated similar geopolitical "drama". The community is actively debating the potential for broader trade implications and forthcoming economic and political developments to shape near-term direction.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as renewed tariff threats regarding Greenland trigger market volatility, with the community sharply divided between those anticipating a significant correction and "buy the dip" proponents. Investors are weighing escalating geopolitical tensions and rising treasury yields against historical market resilience and expectations for a robust tech earnings season.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Shares of Trump Media & Technology Group are trending as recent statements from Donald Trump regarding Greenland's acquisition and associated tariff threats on European nations spark intense debate. The community is actively discussing the geopolitical implications and potential market volatility, with sentiment largely driven by reactions to these prominent political headlines.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin (APP) is experiencing significant recent volatility and a notable pullback, sparking intense community debate. While bulls highlight strong fundamental growth from its AI-powered AXON platform and recent analyst upgrades as a "buy the dip" opportunity, bears point to circulating short report rumors and broader ad-tech sector weakness, alongside discussions of options market dynamics, as reasons for the sharp decline. This creates a highly active discussion about the stock's near-term direction ahead of upcoming earnings.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF (UVIX) is seeing intense discussion as escalating geopolitical tensions, from US actions in Venezuela and Greenland to EU tariff disputes and potential escalations with Iran and China, fuel expectations for a market-wide fear spike. Traders are actively positioning for a major upward move in volatility, leveraging UVIX for short-term hedges while widely acknowledging its pronounced decay characteristics make it unsuitable for extended holding.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is actively trending, fueled by robust financial results from a key semiconductor manufacturing partner, which underscored accelerating demand for AI-driven hardware. This positive sector news has ignited strong debate among the community, with many anticipating a significant upward movement for NVIDIA, while others caution about potential market dynamics. The broader sentiment highlights NVIDIA's integral position within the expanding AI megatrend.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending with high investor enthusiasm following international approvals for its Anktiva treatment in both lung and bladder cancers, notably a first-in-world non-chemo combo for lung cancer from Saudi Arabia. This significant progress, coupled with reported substantial revenue growth, is generating widespread community discussion about the company's transformative potential in oncology and fueling considerable short squeeze speculation due to high short interest. Investors are closely monitoring further global regulatory developments and anticipating a paradigm shift in cancer treatment as Dr. Patrick Soon-Shiong actively promotes the company's innovative "BioShield" platform.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to heightened geopolitical focus on Greenland's critical mineral resources, with discussions around U.S. tariffs to secure access driving strong investor interest. The company's recent $1.5 billion joint venture with a Saudi Arabian partner, securing 100% offtake for its Tanbreez rare earth project, further solidifies its strategic position. Community sentiment is overwhelmingly bullish, anticipating significant upside as global demand for diversified critical mineral supply chains intensifies.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MULN CRYPTO is trending due to a mix of strong skepticism and active promotion, with many users questioning its legitimacy and connection to the controversial Mullen Automotive stock, often cited as a past "scam." While some in the community label it "garbage" and warn of further losses, a dedicated segment is actively calling for accumulation and anticipating significant price surges for the "Mullen Army" token on the Solana network.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is drawing attention following recent developments in its pipeline, including the acquisition of VLX-1005 and ongoing progress for its lead anticoagulant, tecarfarin, notably through a collaboration with Abbott for pivotal trials. Community discussion is split between excitement over its potential in treating rare cardiovascular conditions and concerns regarding dilution and the need for substantial financing for upcoming clinical milestones. Its ultra-low float is also a key talking point, contributing to observed volatility and the potential for significant price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the thirteen analysts that are covering the firm...

TVTX Stock Falls as FDA Extends Review Timeline for Filspari sNDA

Travere Therapeutics shares fall after the FDA extends its review timeline for Filspari's sNDA in FSGS, pushing the decision date to April 2026.

BEAM Outlines Key Strategic & Pipeline Goals for 2026, Stock Rises

Beam Therapeutics jumps 22% after outlining 2026 pipeline goals, including accelerated approval plans for BEAM-302 and a potential risto-cel BLA filing.

Immunocore (IMCR) Upgraded to Strong Buy: Here's What You Should Know

Immunocore (IMCR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Get Free Report) have been given an average rating of "Moderate Buy" by the twelve brokerages that are currently covering the stock...

Hudson Bay Capital Management LP Sells 49,382 Shares of Immunocore Holdings PLC Sponsored ADR $IMCR

Hudson Bay Capital Management LP reduced its stake in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Free Report) by 12.5% in the second quarter, according to the company in its most recent...

Eschler Asset Management LLP Invests $1.26 Million in Immunocore Holdings PLC Sponsored ADR $IMCR

Eschler Asset Management LLP acquired a new position in shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Free Report) in the second quarter, according to its most recent 13F filing with...

1,024,288 Shares in Immunocore Holdings PLC Sponsored ADR $IMCR Purchased by BVF Inc. IL

BVF Inc. IL bought a new stake in shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought...

Bellevue Group AG Increases Stake in Immunocore Holdings PLC Sponsored ADR $IMCR

Bellevue Group AG boosted its position in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Free Report) by 99.9% in the 2nd quarter, according to the company in its most recent disclosure with...

Immunocore Holdings PLC Sponsored ADR $IMCR Stock Position Lowered by Armistice Capital LLC

Armistice Capital LLC trimmed its position in shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Free Report) by 30.7% during the 2nd quarter, according to the company in its most recent...

Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.

IMCR
Immunocore Holdings PLC - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IMCR News

IMCRImmunocore Holdings PLC - ADR